Matthew Harrison
Stock Analyst at Morgan Stanley
(3.40)
# 821
Out of 4,814 analysts
734
Total ratings
46.21%
Success rate
1.66%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SRPT Sarepta Therapeutics | Maintains: Overweight | $196 → $182 | $53.79 | +238.35% | 35 | Apr 11, 2025 | |
| AVIR Atea Pharmaceuticals | Maintains: Equal-Weight | $6.2 → $6 | $2.97 | +102.02% | 10 | Apr 11, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $157 → $152 | $118.61 | +28.15% | 52 | Apr 9, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $39 → $32 | $24.73 | +29.42% | 25 | Apr 9, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $82 → $80 | $32.77 | +144.13% | 11 | Mar 17, 2025 | |
| TSVT 2seventy bio | Maintains: Equal-Weight | $6 → $5 | $4.98 | +0.40% | 10 | Mar 14, 2025 | |
| TNYA Tenaya Therapeutics | Maintains: Overweight | $15 → $5 | $0.45 | +1,011.11% | 5 | Mar 12, 2025 | |
| GILD Gilead Sciences | Maintains: Overweight | $123 → $130 | $104.53 | +24.37% | 40 | Mar 11, 2025 | |
| DNLI Denali Therapeutics | Assumes: Overweight | $41 → $33 | $12.72 | +159.43% | 12 | Mar 7, 2025 | |
| LYV Live Nation Entertainment | Maintains: Buy | $160 → $178 | $127.34 | +39.78% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $31.21 | +79.43% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $450 → $459 | $489.10 | -6.15% | 37 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $85 → $90 | $72.47 | +24.19% | 16 | Feb 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $33.99 | +61.84% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $0.93 | +222.79% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $1,235 → $1,184 | $563.16 | +110.24% | 50 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $4 → $6 | $0.86 | +597.67% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $12.25 | -10.20% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $38 → $8 | $1.30 | +517.76% | 4 | Jun 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $515 → $510 | $593.60 | -14.08% | 24 | May 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $1.29 | +444.75% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $115 → $112 | $59.12 | +89.45% | 21 | Apr 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $34 | $14.00 | +142.86% | 14 | Apr 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $19.55 | +63.68% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $1.24 | +1,438.46% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Underweight | $60 | $4.15 | +1,345.78% | 30 | Jul 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $13 | $1.74 | +647.13% | 4 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $0.51 | +96.08% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $18.27 | -45.27% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $3.06 | +161.44% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $24.72 | +78.03% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $1.64 | +692.68% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $4 | $0.43 | +821.66% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $5 → $3 | $0.34 | +790.21% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $98.76 | +118.71% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $1.23 | +308.16% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.53 | +226.80% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $173.00 | +5.20% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $2.84 | +216.90% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $37.65 | +6.26% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $277.29 | +1.70% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $234.75 | -10.54% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $22.15 | +134.82% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $157.44 | +9.88% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $61 → $57 | $7.44 | +666.64% | 9 | Mar 10, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $35.64 | +236.70% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $20.35 | +627.27% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $77.98 | +5.16% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $49.23 | +34.08% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $1.25 | +3,020.00% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $32.51 | +41.49% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $11.12 | +214.75% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $839.90 | -67.26% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $1.87 | +916.04% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $5.96 | +940.27% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $13.27 | +29.99% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $50 | $0.95 | +5,163.16% | 4 | Aug 18, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $58.22 | +42.56% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $59 → $57 | $29.10 | +95.88% | 4 | Oct 11, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $39.48 | -74.67% | 4 | Sep 10, 2018 |
Sarepta Therapeutics
Apr 11, 2025
Maintains: Overweight
Price Target: $196 → $182
Current: $53.79
Upside: +238.35%
Atea Pharmaceuticals
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $2.97
Upside: +102.02%
Biogen
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $157 → $152
Current: $118.61
Upside: +28.15%
Moderna
Apr 9, 2025
Maintains: Equal-Weight
Price Target: $39 → $32
Current: $24.73
Upside: +29.42%
Legend Biotech
Mar 17, 2025
Maintains: Overweight
Price Target: $82 → $80
Current: $32.77
Upside: +144.13%
2seventy bio
Mar 14, 2025
Maintains: Equal-Weight
Price Target: $6 → $5
Current: $4.98
Upside: +0.40%
Tenaya Therapeutics
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $0.45
Upside: +1,011.11%
Gilead Sciences
Mar 11, 2025
Maintains: Overweight
Price Target: $123 → $130
Current: $104.53
Upside: +24.37%
Denali Therapeutics
Mar 7, 2025
Assumes: Overweight
Price Target: $41 → $33
Current: $12.72
Upside: +159.43%
Live Nation Entertainment
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $127.34
Upside: +39.78%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $31.21
Upside: +79.43%
Feb 11, 2025
Maintains: Equal-Weight
Price Target: $450 → $459
Current: $489.10
Upside: -6.15%
Feb 6, 2025
Maintains: Overweight
Price Target: $85 → $90
Current: $72.47
Upside: +24.19%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $33.99
Upside: +61.84%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $0.93
Upside: +222.79%
Nov 1, 2024
Maintains: Overweight
Price Target: $1,235 → $1,184
Current: $563.16
Upside: +110.24%
Sep 16, 2024
Maintains: Overweight
Price Target: $4 → $6
Current: $0.86
Upside: +597.67%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $12.25
Upside: -10.20%
Jun 18, 2024
Downgrades: Equal-Weight
Price Target: $38 → $8
Current: $1.30
Upside: +517.76%
May 28, 2024
Maintains: Overweight
Price Target: $515 → $510
Current: $593.60
Upside: -14.08%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $1.29
Upside: +444.75%
Apr 26, 2024
Maintains: Overweight
Price Target: $115 → $112
Current: $59.12
Upside: +89.45%
Apr 22, 2024
Maintains: Overweight
Price Target: $34
Current: $14.00
Upside: +142.86%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $19.55
Upside: +63.68%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $1.24
Upside: +1,438.46%
Jul 11, 2023
Reiterates: Underweight
Price Target: $60
Current: $4.15
Upside: +1,345.78%
Mar 27, 2023
Maintains: Equal-Weight
Price Target: $12 → $13
Current: $1.74
Upside: +647.13%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $0.51
Upside: +96.08%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $18.27
Upside: -45.27%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $3.06
Upside: +161.44%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $24.72
Upside: +78.03%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $1.64
Upside: +692.68%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $4
Current: $0.43
Upside: +821.66%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $5 → $3
Current: $0.34
Upside: +790.21%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $98.76
Upside: +118.71%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $1.23
Upside: +308.16%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.53
Upside: +226.80%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $173.00
Upside: +5.20%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $2.84
Upside: +216.90%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $37.65
Upside: +6.26%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $277.29
Upside: +1.70%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $234.75
Upside: -10.54%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $22.15
Upside: +134.82%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $157.44
Upside: +9.88%
Mar 10, 2022
Maintains: Equal-Weight
Price Target: $61 → $57
Current: $7.44
Upside: +666.64%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $35.64
Upside: +236.70%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $20.35
Upside: +627.27%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $77.98
Upside: +5.16%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $49.23
Upside: +34.08%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $1.25
Upside: +3,020.00%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $32.51
Upside: +41.49%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $11.12
Upside: +214.75%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $839.90
Upside: -67.26%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $1.87
Upside: +916.04%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $5.96
Upside: +940.27%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $13.27
Upside: +29.99%
Aug 18, 2020
Downgrades: Equal-Weight
Price Target: $50
Current: $0.95
Upside: +5,163.16%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $58.22
Upside: +42.56%
Oct 11, 2018
Maintains: Overweight
Price Target: $59 → $57
Current: $29.10
Upside: +95.88%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $39.48
Upside: -74.67%